These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12806672)

  • 1. [COX-2 inhibitors and their effects on kidney and blood pressure].
    Os I
    Tidsskr Nor Laegeforen; 2003 May; 123(10):1339-41. PubMed ID: 12806672
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-inflammatory drugs may put on the pressure.
    Harv Heart Lett; 2003 Mar; 13(7):7. PubMed ID: 12654586
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe cholestasis and acute renal failure related to rofecoxib.
    Linares P; Vivas S; Jorquera F; Olcoz JL; de Leon B; Oritz de Urbina J
    Am J Gastroenterol; 2004 Aug; 99(8):1622-3. PubMed ID: 15307886
    [No Abstract]   [Full Text] [Related]  

  • 4. The COX 2 selective inhibitors: what the newspapers have not told you.
    Simon LS
    Bull NYU Hosp Jt Dis; 2007; 65(3):229-41. PubMed ID: 17922675
    [No Abstract]   [Full Text] [Related]  

  • 5. [Selective COX-2 inhibitors--side effects in relation to non-specific non-steroidal anti-inflammatory drugs].
    Hansen JM; de Muckadell OB
    Ugeskr Laeger; 2004 Dec; 166(50):4581-4. PubMed ID: 15633545
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nonsteroidal antirheumatics and the kidney].
    Galesić K; Morović-Vergles J; Jelaković B
    Reumatizam; 2005; 52(2):61-6. PubMed ID: 16689132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Safety of selective inhibitors of inducible cyclooxygenase-2 taken for a long period].
    Lamarque D
    Bull Cancer; 2004 May; 91 Spec No():S117-24. PubMed ID: 15239340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the pro-hypertensive effect of cyclooxygenase-2 inhibitors account for the increased risk in cardiovascular disease?
    Messerli FH; Sichrovsky T
    Am J Cardiol; 2005 Sep; 96(6):872-3. PubMed ID: 16169380
    [No Abstract]   [Full Text] [Related]  

  • 9. [Heart failure and fluid retention attributed to the use of non-steroidal anti-inflammatory drugs].
    Feenstra J; Stricker BH
    Ned Tijdschr Geneeskd; 1996 Oct; 140(40):2000-3. PubMed ID: 8965931
    [No Abstract]   [Full Text] [Related]  

  • 10. COX-2 inhibitors may raise blood pressure.
    Health News; 2005 Jun; 11(6):2. PubMed ID: 16127788
    [No Abstract]   [Full Text] [Related]  

  • 11. [NSAIDs and coxibs raise blood pressure].
    Krankenpfl J; 2005; 43(7-10):199. PubMed ID: 16515271
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse cardiovascular effects of NSAIDs: driven by blood pressure, or edema?
    Aneja A; Farkouh ME
    Ther Adv Cardiovasc Dis; 2008 Feb; 2(1):53-66. PubMed ID: 19124408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal effects of non-narcotic analgesics and non-steroidal anti-inflammatory drugs].
    Tareeva IE; Androsova SO
    Ter Arkh; 1999; 71(6):17-22. PubMed ID: 10420449
    [No Abstract]   [Full Text] [Related]  

  • 14. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
    Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG;
    Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adverse kidney effects of nonsteroidal anti-inflammatory agents-- current physiopathological and clinical aspects].
    Duţu A; Parasca I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1987; 39(5):405-14. PubMed ID: 2894058
    [No Abstract]   [Full Text] [Related]  

  • 16. [Non-steroidal anti-inflammatory drugs: predictably nephrotoxic in various groups of subjects].
    Stehouwer CD; Donker AJ
    Ned Tijdschr Geneeskd; 1991 Mar; 135(11):455-7. PubMed ID: 2023649
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analgesics and kidney].
    Aitio ML
    Duodecim; 1998; 114(9):841-8. PubMed ID: 11524803
    [No Abstract]   [Full Text] [Related]  

  • 18. [COX 2 inhibitors--a further step back].
    Slørdal L; Evensen S; Spigset O
    Tidsskr Nor Laegeforen; 2005 Apr; 125(8):1046. PubMed ID: 15852094
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative cardiovascular safety of traditional nonsteroidal anti-inflammatory drugs.
    Maillard M; Burnier M
    Expert Opin Drug Saf; 2006 Jan; 5(1):83-94. PubMed ID: 16370958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COX-2 selective nonsteroidal anti-inflammatory drugs: current status.
    Mahajan A; Sharma R
    J Assoc Physicians India; 2005 Mar; 53():200-4. PubMed ID: 15926604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.